VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1650523
Sex: F
Age:
State: DE

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Had unbearable indigestion and heartburn and belching/ excessive burping; The evening of the shot, started having bad indigestion and heartburn; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration on 11Apr2021 at 12:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD) and coronary artery disease (CAD). The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPRIN), lansoprazole (LANSOPRAZOL) and sambucus nigra (ELDERBERRY); all taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 11Apr2021 at 20:00, the evening of the shot, the patient started having bad indigestion and heartburn. The following day, on 12Apr2021, it worsened and persisted and was really quite awful and the patient had unbearable indigestion heart burn and belching. The symptoms finally dissipated about 48 hours later. The patient had no nausea, it was strictly heartburn and indigestion excessive burping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event the evening of the shot, started having bad indigestion and heartburn was recovered on an unknown date in Apr2021. The clinical outcome of the event unbearable indigestion and heartburn and belching/excessive burping was recovered on 12Apr2021.

Other Meds: ROSUVASTATIN; ASPRIN; LANSOPRAZOL; ELDERBERRY [SAMBUCUS NIGRA]

Current Illness:

ID: 1650524
Sex: M
Age:
State: MO

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Sore muscle at injection site; Inflammation in both hands and wrists; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Lot 8731) via an unspecified route of administration in the right arm on 16Apr2021 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. Concomitant medications included prednisone (MANUFACTURER UNKNOWN), trazodone (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and bupropion (MANUFACTURER UNKNOWN) for unknown indication from an unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Lot ER2613) via an unspecified route of administration in the right arm on 25Mar2021 at 12:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 14:00 the patient experienced sore muscle at injection site and inflammation in both hands and wrists. No therapeutic measures were taken as a result of reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vaccination site pain was unknown. The clinical outcome of the event inflammation was recovered on 16Apr2021 at 14:00. No follow-up attempts are needed. No further information is expected.

Other Meds: PREDNISONE; TRAZODONE; OMEPRAZOLE; BUPROPION

Current Illness:

ID: 1650525
Sex: F
Age:
State: TX

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210414; Test Name: Body temperature; Result Unstructured Data: Test Result:99 plus; Comments: 99+* fever

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Swollen lymph nodes under right arm; Armpit swelled up considerably and experienced lots of pain; Armpit swelled up considerably and experienced lots of pain; Hot to the touch; Soreness in arm; Aches and pains; 99 plus fever; Tiredness; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 17:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, hypothyroidism, overweight and prior to the vaccination, the patient was diagnosed with COVID-19. The patient was allergic to sulfur meds (drug allergy). Concomitant medications included celecoxib (CELEBREX), levothyroxine sodium (SYNTHROID), vitamin d nos (VITAMIN D), sertraline (MANUFACTURER UNKNOWN) and phendimetrazine tartrate (PHENTRA) all for an unknown indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, after shot, the patient had soreness in arm, aches and pains, 99 plus (unspecified units) fever and tiredness; about 24 hours after shot at 18:00, the patient developed swollen lymph nodes under right arm, armpit swelled up considerably and experienced lots of pain and it was hot to the touch. At the time of this report (still), it was very swollen and painful 3 days after shot, no longer hot to the touch and the patient still experienced slight aches as well. Since the vaccination, the patient had been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported adverse events. The clinical outcome of the event hot to the touch was resolved on an unknown date in Apr2021, whereas the clinical outcome of the events soreness in arm, aches and pains, 99 plus fever, tiredness, swollen lymph nodes under right arm, armpit swelled up considerably and experienced lots of were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: CELEBREX; SYNTHROID; VITAMIN D NOS; SERTRALINE; PHENTRA

Current Illness:

ID: 1650526
Sex: F
Age:
State: WI

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Insomnia; Metallic taste; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 17:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took cefazolin sodium (ANCEF) for an unknown indication on an unknown date and experienced allergy. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 00:00, the patient experienced insomnia and metallic taste. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of insomnia and metallic taste was recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650527
Sex: M
Age:
State: CT

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Fever; Chills; Headache; Nausea; Racing heart; This is a spontaneous report from a contactable consumer. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12Apr2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. Concomitant medications included atenolol (MANUFACTURER UNKNOWN); from unknown date for unknown indication and unknown if on going. The patient had no known allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced fever, chills, headache, nausea and racing heart. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. . The patient did not receive any treatment for the reported event. The clinical outcome of the events of fever, chills, headache, nausea and racing heart was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: ATENOLOL

Current Illness:

ID: 1650528
Sex: M
Age:
State: LA

Vax Date: 04/06/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:100.4 Units:{DF}; Test Date: 20210413; Test Name: Rapid test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 06Apr2021(at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient had known allergy to Sulfa. The patient did not receive any other medication within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021(at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 the patient experienced fever of 100.4 (unspecified units) and chills and continue to have these symptoms till 14Apr2021. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 13Apr2021, the patient underwent rapid test (nasal swab) and the result was negative. The clinical outcome of the event fever and chills was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650529
Sex: F
Age:
State: NY

Vax Date: 04/09/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: I had mild temperature; Fatigue; Body ache; Rashes throughout my body; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 09Apr2021 at 12:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had known allergies to Ibuprofen (MANUFACTURER UNKNOWN). Concomitant medications included escitalopram oxalate (LEXAPRO) for unknown indication, on unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021, the patient experienced mild temperature, fatigue, body ache for about 36 hours after getting the dose, which was expected and rashes throughout body. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse event. The clinical outcome of the event's mild temperature, fatigue, body ache and rashes throughout body was recovering at the time of this report. No follow up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LEXAPRO

Current Illness:

ID: 1650530
Sex: M
Age:
State: TX

Vax Date: 04/06/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received an unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EP7533), at the age of 46, via an unspecified route of administration, left arm, on Apr 6, 2021, at 18:15, single dose, for COVID-19 immunisation. The patient has not reported any other health issues. The patient has no known allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On Apr 10, 2021, patient's left arm ached too much from last 3 days. He could not carry even a pound. Since the vaccination, patient has not been tested for COVID-19. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the left arm ached too much from last 3 days not recovered (at the time of this report). No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1650531
Sex: F
Age:
State: GA

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Within a few minutes after my 1st Covid 19 vaccine my throat and tongue began to swell up; Within a few minutes after my 1st Covid 19 vaccine my throat and tongue began to swell up; Skin started to turn red all over; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 14:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 at 14:00, within few minutes after the first vaccine patient's throat and tongue began to swell up and the skin started to turn red all over. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with diphenhydramine (BENADRYL) on site by a Registered Nurse. The clinical outcome of the events throat swelling, tongue swelling and skin started to turn red all over was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650532
Sex: F
Age:
State:

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: experiencing some numbness; tingling in tongue; tingling in lips on the left side; site soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 14Apr2021 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Allergies to medications, food, or other products were reported as not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. Patient previously received first dose BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205) in the left arm on 19Mar2021 (at the age of 52-year-old) as a single dose for COVID-19 Vaccination. On 14Apr2021 the patient experienced 4 hours after the stick, experienced some numbness/ tingling in tongue and lips on the left side only. Only other side effect is site soreness. Therapeutic measures were taken as a result of the events, numbness/ tingling in tongue and lips on the left side only. Only other side effect is site soreness which included treatment with dyphenhydramine. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event experiencing some numbness/tingling in my tongue and lips on the left side only and only other side effect is site soreness was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1650533
Sex: F
Age:
State: OH

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Felt flush in face; Headache; Achy; Tired; General feeling of being unwell.; Sore arm at the site of the injection.; This is a spontaneous report received from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included vitamin nos (DAILY MULTIVITAMIN), colecalciferol (VITAMIN D3) 5000 IU, all for unknown indication, for unknown period of time. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613 ), via an unspecified route of administration in the left arm on 19Mar2021, at 16:30 as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 14:30, the patient reported that she received second dose of the Pfizer BioNTech vaccine at 12 noon on 12Apr2021 and by 2:30 pm felt flush in her face, headache, achy, tired and general feeling of being unwell. She also experienced sore arm at the site of the injection. These symptoms continued on 12Apr2021 and 13Apr2021. On 14Apr2021 she felt better upon waking up. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events achy, tired, general feeling of being unwell, sore arm at the site of the injection were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D3; DAILY MULTIVITAMIN

Current Illness:

ID: 1650534
Sex: F
Age:
State: TN

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Heart racing; Dizziness; Bad muscle aches; Fatigue; Felt absolutely terrible; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the left arm on 26Mar2021 at 13:30 (at the age of 50-years-old) as a dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021 at 13:45, the patient reported that she had bad side effects which included heart racing, dizziness initially and then bad muscle aches, fatigue; the patient felt absolutely terrible for the next 3 days. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the events heart racing, dizziness initially, bad muscle aches, fatigue and felt absolutely terrible were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650535
Sex: F
Age:
State: PA

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Painful Intertrigo on waist and lower abdomen/ intertrigo rash; Painful herpes outbreak all over mylower left arm and lower back; immune system was compromised; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 08Apr2021 at 11:00 (at the age of 68-year-old) at single dose for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included herpes infection in 1975, bad back issues, high cholesterol, adhesive tape allergy. Concomitant medications included unspecified vitamins and eye drops. The patient previously took cefalexin (KEFLEX) on an unknown date and experienced constipation. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 18Mar2021 at 10:30 (at the age of 68-year-old) as single dose for COVID-19 immunization; no issues after first injection. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 20:30 (also reported as between 29-30 hours after her second shot), patient experienced very painful intertrigo on waist and lower abdomen (which she have never had) and had a painful herpes outbreak all over lower left arm and lower back. These happened at the same time. She has not had a herpes outbreak in over 30 years. She had no issues after her 1st injection and she have not heard of this occurrence happening as a side effect, but she cannot overlook the timing that both of these concurrent skin rashes happened within 28-30 hours of 2nd Pfizer shot. She went to her PCP and it was confirmed that she had a herpes outbreak and an intertrigo rash and that it's possible that her immune system was compromised somehow that caused this to occur. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of these events which included treatment with valacyclovir and ketoconazole cream. The clinical outcome of the events (very painful intertrigo on waist and lower abdomen (which she have never had)/ intertrigo rash, and had a painful herpes outbreak all over lower left arm and lower back, immune system was compromised) was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650536
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: "Whooshing"/rushing sound in my left ear for 2 days; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 12:30 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included oxybutynin hydrochloride (OXYBUTININ ACCORD) from an unknown date for unknown indication and unknown if its ongoing. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9264) via an unspecified route of administration in the left arm on 17Mar2021 at 12:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 08:00, the patient experienced "whooshing"/rushing sound in her left ear for 2 days. No therapeutic measures were taken as a result of the reported event. The adverse event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event "whooshing"/rushing sound in her left ear for 2 days was recovered on 17Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: OXYBUTININ ACCORD

Current Illness:

ID: 1650537
Sex: F
Age:
State: AZ

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210409; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: unwell with chest and head infection; unwell with chest and head infection; bad upper respiratory infection; cough; unwell with chest and head infection; bad diarrhea; headache; This is a spontaneous report from a contactable consumer (patient herself). A non-pregnant 61-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration, administered in left arm on 03Apr2021 13:30 (Batch/Lot Number: ER8734) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history was not reported. No COVID prior vaccination. The patient's concomitant medications were not reported. No other vaccine in 4 weeks. Patient previously took iodine for an unspecified indication and experienced known allergies. On 04Apr2021, the day after shot had bad diarrhea and headache but on 05Apr2021, the second day after shot, patient came down with a bad upper respiratory infection. Went to doctor she gave her some pills for the cough. Patient have been unwell with chest and head infection. Never coughed so much in her life. The adverse event resulted in doctor or other healthcare professional office/clinic visit and treated with benzonatate. COVID was tested post vaccination via nasal swab on 09Apr2021 with result negative. Facility type vaccine was Public Health facility. The outcome of the events was not recovered at the time of report.

Other Meds:

Current Illness:

ID: 1650538
Sex: F
Age:
State: GA

Vax Date: 03/11/2021
Onset Date: 03/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Back pain started then vesicles the next day with rash on right torso; Nerve pain accompanied the itching; Nerve pain accompanied the itching; Shingles outbreak 5 days post vaccine; Back pain started; This is a spontaneous report from a contactable nurse, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 11Mar2021 at 13:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included Hypertension (HTN), adrenal insufficiency and hypothyroidism. The patient was allergic to fish. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID), hydrocortisone (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) and vitamin D (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously took morphine and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, 5 days post vaccine, the patient experienced shingles outbreak which started with back pain. On 17Mar2021, the next day, vesicles appeared with rash on right torso and nerve pain accompanied with itching. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with Valtrex from 19Mar2021 for a duration of 7 days. The vesicles had dried up by 30Mar2021 and the pain had subsided, but the patient still had some residual nerve pain on torso when touched. The clinical outcome of the events shingles, back pain, vesicles with rash on right torso and nerve pain accompanied with itching were resolved with lasting effects on 30Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ATENOLOL; SYNTHROID; HYDROCORTISONE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1650539
Sex: M
Age:
State: VA

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Right (opposite) arm and hand felt a little numb; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 17:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took bupropion hydrochloride (WELLBUTRIN), itraconazole (SPORANOX) for an unknown indication on an an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 19:00, the patient experienced right (opposite) arm and hand felt a little numb a couple of hours after the vaccination, and still felt that way the next day, but to a lesser degree. The patient felt like the feeling when she get a limb "falls asleep". The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right (opposite) arm and hand felt a little numb was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650540
Sex: F
Age:
State: CA

Vax Date: 04/13/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Rash on face and neck 3 days after first dose.; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the left arm on13Apr2021 at 12:30 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and alpha thalassemia. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol, levonorgestrel (JOLESSA) taken for birth control from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 11:15, 3 days after the first dose, the patient experienced rash on face and neck. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on face and neck was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: JOLESSA

Current Illness:

ID: 1650541
Sex: F
Age:
State: CA

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Body aches; Low grade fever; Chills; Nausea; Headache; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 12Apr2021 at 08:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received an unspecified vaccine within four weeks prior to the COVID vaccine. Concomitant medications included unspecified birth control medication from an unknown date for an unknown indication and unknown if ongoing. On 12Apr2021 at 20:30, the patient experienced low grade fever, chills, nausea, body aches and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade fever, chills, nausea, body aches and headache were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650542
Sex: F
Age:
State: CO

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Headache; Taste of metal in mouth; Ringing in the ears; Elevated heart rate; Blurry vision; Arms soreness; Muscle, bone and joint pain.; Muscle, bone and joint pain.; Muscle, bone and joint pain.; This is a spontaneous report from a contactable healthcare professional, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the right arm on 03Apr2021 at 11:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer and bi lateral mastectomy. The patient had known allergies to iodine, all antibiotics, shellfish, latex and gadolinium. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:30, the patient experienced headache that lasted a week, taste of metal in mouth that lasted a week, ringing in the ears, elevated heart rate, blurry vision, arms soreness, muscle, bone and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and taste of metal in mouth was recovered on 10Apr2021; while that of the ringing in the ears, elevated heart rate, blurry vision, arms soreness, muscle, bone and joint pain was recovered on unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650543
Sex: F
Age:
State: CA

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Pain scale; Result Unstructured Data: Test Result:4 on the pain scale of 10; Test Date: 20210211; Test Name: Pain scale; Result Unstructured Data: Test Result:9 on the pain scale of 10

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Excruciating pain in the right knee joint; Could barely walk; Knee joint swelled, so right knee measured 1 inch greater than left knee.; Left knee was sore; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: GL8982) via an unspecified route of administration in the left arm on 11Feb2021 at 09:30 (at the age of 74-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021 at 09:30 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included angelica sinensis root (DONG QUAI), tocopheryl acetate (VITAMIN E), vitamin b complex (VITAMIN B), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and hormone replacement therapy; all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Feb2021 at 16:30, the day of the first shot, the patient experienced excruciating pain in the right knee joint, pain was 9 on the pain scale of 10, the patient could barely walk, knee joint swelled, the patient's right knee measured 1 inch greater than left knee. For four weeks the patient was in pain, just walked to the car, went up and down stairs one leg at a time. The patient's right knee got better after five weeks. On an unknown date in 2021, the patient experienced left knee was sore. Pain level was about a 4 on the scale of 10. Before the shot, the patient was walking regularly about 10 miles a week but walking was now limited to several blocks' maximum. Since the right knee improved over 5 weeks, the patient had to assume the left knee would also improve. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with multiple acupuncture, chiropractic, physical therapy treatments, ice, salonpas patches and ibuprofen. On 11Feb2021, the patient underwent pain scale assessment and the result was 9 on the pain scale of 10. On an unknown date in 2021, the patient underwent pain scale assessment and the result was 4 on the pain scale of 10. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events excruciating pain in the right knee joint, could barely walk, right knee joint swelled and left knee was sore was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: DONG QUAI; VITAMIN E [TOCOPHERYL ACETATE]; VITAMIN B [VITAMIN B COMPLEX]; CALCIUM; MAGNESIUM

Current Illness:

ID: 1650544
Sex: F
Age:
State: AR

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Fever; chills; achy joints; sore throat; upset stomach; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 13Apr2021 at 13:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included tachycardia. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL), vitamin b12 nos (VITAMIN B12), cetirizine hydrochloride (ZYRTEC) and ethinylestradiol, drospirenone (NIKKI) all from an unknown date and unknown if ongoing for an unknown indication. The patient previously took hydrocodone (MANUFACTURER UNKNOWN) and experienced allergy. On 14Apr2021 at 07:00, the patient experienced fever, chills, achy joints, sore throat, upset stomach. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, achy joints, sore throat, upset stomach was not recovered at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADDERALL; VITAMIN B12 [VITAMIN B12 NOS]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; NIKKI

Current Illness:

ID: 1650545
Sex: M
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Sore arm; tired; foggy; chills; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 13Apr2021 at 09:30(at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included allergy medicines and ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 23Mar2021 at 16:45 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 20:30 the patient experienced sore arm, tired, foggy, chills. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcomes of the events sore arm, tired, foggy, chills were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1650546
Sex: F
Age:
State: AR

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Within 6 hours of the 2nd vaccine the injection site swelled up/ a "knit the size of a quarter"; Turned feverish; Within 6 hours of the 2nd vaccine. the injection site hurt/ arm hurts where "knit" is located.; "The redness is gone."; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER732) via an unspecified route of administration in the right arm on 09Apr2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included hypothyroidism and arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), estradiol (MANUFACTURER UNKNOWN) and montelukast (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously took codeine and experienced a drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6299) via an unspecified route of administration in the left arm on 19Mar2021 at 13:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 19:00, within 6 hours of the second vaccine the patient reported that the "injection site swelled up, turned feverish, and hurt." The patient reported that on 14Apr2021, 6 days after the vaccination (at the time of this report) she had a "knit the size of a quarter." The redness had gone and her arm hurt where the "knit was located." Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events redness was resolved on 14Apr2021; while the clinical outcome of the events injection site swelled up, turned feverish, and hurt, she had a "knit the size of a quarter", arm hurt where the "knit was located" were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: OMEPRAZOLE; LOSARTAN; ESTRADIOL; MONTELUKAST

Current Illness:

ID: 1650547
Sex: F
Age:
State: NH

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Dizziness on and off; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 23Mar2021 at 00:45 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. Medical history included Hx leiomyosarcoma, high cholesterol and overweight. The patient was allergic to Regalan and IVP dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included anastrozole (MANUFACTURER UNKNOWN) from an unknown date and unknown if ongoing for an unknown indication. On 24Mar2021 at 12:00, the patient experienced dizziness on and off. Therapeutic measures were not taken as a result of the event. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness on and off was resolved on 24Mar2021 at 18:00. No follow-up attempts are needed. No further information is expected.

Other Meds: ANASTROZOLE

Current Illness:

ID: 1650548
Sex: F
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: tingling lips; swelling sensation in throat; sore arm; headache; chills and fever; chills and fever; achy; arm tired; This is a spontaneous report from a non-contactable consumer. A non-pregnant female patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 09:00, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Mar2021 at 09:00, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced tingling lips, swelling sensation in throat, sore arm, headache, chills and fever, achy and arm tired. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tingling lips, swelling sensation in throat, sore arm, headache, chills and fever, achy and arm tired was recovering at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650549
Sex: F
Age:
State: TX

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Arm pain (injection site); Fever; tiredness; Muscle ache; Joint pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EOW158) via an unspecified route of administration on the left arm on 13Apr2021 at 10:15(at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not take any concomitant medication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 13:00 the patient experienced arm pain (injection site), fever, headache, tiredness, muscle ache and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events vaccination site pain, fever, headache, tiredness, muscle ache and joint pain was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650550
Sex: F
Age:
State: MD

Vax Date:
Onset Date: 03/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Itchy bumps on skin; Itchy bumps on skin; This is a spontaneous report from a non-contactable consumer. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date in 2021 and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on an unknown date in 2021, as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown whether the patient received any other medications in two weeks of vaccination. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown whether the patient receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, the patient experienced itchy bumps on skin. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event itchy bumps on skin was unknown at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650551
Sex: F
Age:
State: MA

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Parotid gland swelling; This is a spontaneous report from a contactable physician, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 13Apr2021 at 10:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), nifedipine (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA), vitamin d nos (MANUFACTURER UNKNOWN) and curcuma longa (TURMERIC) all for an unknown indication on an unknown date and unknown if ongoing. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 23Mar2021 at 10:15 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 00:00, the patient experienced parotid gland swelling. The event did not result in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event parotid gland swelling was recovering at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; NIFEDIPINE; ALLEGRA; VITAMIN D [VITAMIN D NOS]; TURMERIC [CURCUMA LONGA]

Current Illness:

ID: 1650552
Sex: F
Age:
State:

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Vaccination site pain; Tiredness; Headache; Muscle pain; Chills; Joint pain; Fever; Nausea; Feeling unwell; Dizzy; This is a spontaneous report from a non-contactable consumer. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 10Apr2021 at 15:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and unspecified allergy. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6Z06) via an unspecified route of administration in the left arm on 19Mar2021 at 12:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 05:30, the patient experienced vaccination site pain, tiredness, headache, muscle pain, chills, joint, pain, fever, nausea, feeling unwell and dizzy. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events of vaccination site pain tiredness, headache, muscle pain, chills, joint, pain, fever, nausea, feeling unwell and dizzy was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1650553
Sex: F
Age:
State: PA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Fatigue; body ache; chills; This is a spontaneous report from a non-contactable consumer. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 13Apr2021 at 09:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 17:00, the patient experienced fatigue, body aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fatigue, body ache and chills were recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650554
Sex: F
Age:
State: MD

Vax Date: 04/07/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: bouts of depression within a week after shot; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021 at 12:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medication within two weeks of taking the COVID-19 vaccine. On 11Apr2021, the patient experienced bouts of depression within a week after the shot similar to postpartum depression, no history of depression or mental illness. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event bouts of depression within a week after the shot similar to postpartum depression was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650555
Sex: F
Age:
State:

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Huge migraine; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 13Apr2021 at 18:00(at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other product. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021 at 18:30, the patient experienced huge migraine. The patient stated that migraine was getting worse. The patient did not receive any treatment for the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event huge migraine was ongoing at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650556
Sex: F
Age:
State: VA

Vax Date: 04/01/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 01Apr2021 at 08:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of the COVD-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 14Apr2021 at 09:30, the patient woke up with a horizontal rash along the side of the upper right torso. It stretched from just below the side of her right breast toward the center of her back. On 16Apr2021, it was diagnosed as shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with VALTREX EQ and pain medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650557
Sex: F
Age:
State: MT

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Left side sensation skin is burning gets hoter if I was with water also; occipital neuralgia; 2nd and third day I've been tired; 12 hours after 2nd dose woke up at 4am; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 14Apr2021 at 16:15 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. The patient was allergic to sulfa. Concomitant medications included prednisone (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), vitamin D3 (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) and magnesium (MANUFACTURER UNKNOWN) all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 24Mar2021 at 04:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 04:00,12 hours after vaccination the patient woke up at 4 am. On 16Apr2021 the patient experienced tired, left side sensation of skin burning gets hotter if was with water also and had occipital neuralgia. These events occurred on second and third day of vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 12 hours after vaccination the patient woke up at 4 am, tired, left side sensation of skin burning gets hotter if was with water also and had occipital neuralgia was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: PREDNISONE; GABAPENTIN; IBUPROFEN; VITAMIN D3; ASPIRIN [ACETYLSALICYLIC ACID]; MAGNESIUM

Current Illness:

ID: 1650558
Sex: F
Age:
State: TX

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Woke up sweating; Feeling hot but my body felt cool. Felt like I had icy hot all over my body.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 13:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient was allergic to latex and iodine. Prior to the vaccination, the patient was not diagnosed with COVID-19.Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 04:00, the patient woke up sweating, felt hot but her body felt cool. The patient felt like she had icy hot all over her body. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events woke up sweating, felt hot but her body felt cool and felt like she had icy hot all over her body was unknown at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650559
Sex: M
Age:
State: MD

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: High frequency ringing in head.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 03Apr2021 at 13:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks. On 03Apr2021, the patient experienced high frequency ringing in head. The noise that had persisted since approximately 4 hours after vaccine. The patient did not receive any treatment for the reported event. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event high frequency ringing in head was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650560
Sex: M
Age:
State: MI

Vax Date: 03/08/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210415; Test Name: PCR nasal swab for COVID; Test Result: Positive

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: PCR Nasal Swab: Positive/ stuffy nose, general ache, diarrhea and loss of taste; PCR Nasal Swab: Positive/ stuffy nose, general ache, diarrhea and loss of taste; This is a spontaneous report from a contactable nurse. A 32-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 31-years-old, intramuscular in right arm on 15Feb2021 at 13:00 at dose 1, single (lot number: EL3248) and intramuscular in right arm on 08Mar2021 at 12:45 at dose 2, single (lot number: EL3248) for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Known allergies were unknown. The patient has no COVID prior to vaccination. It was unknown if the patient received any other vaccines in four weeks. The patient's concomitant medications were not reported. Facility type was reported as a workplace clinic. On 15Apr2021, the patient began to experience stuffy nose, general ache, diarrhea, and loss of taste. His PCR nasal swab for COVID on the same day was positive. Treatment for the events was unknown. The outcome of the events was recovering.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported vaccination failure / COVID-19 cannot be ruled out.

Other Meds:

Current Illness:

ID: 1650561
Sex: F
Age:
State: VA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Lightheadedness/Dizziness; Felt a warm flush when received dose; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 16Apr2021 at 16:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 26Mar2021 at 16:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 16Apr2021 at 17:30, the patient experienced lightheadedness/dizziness that had persisted into the day after. Felt a warm flush when received dose. Dizziness had even occurred when sitting still. Dizziness came in waves, worsened when the patient moves suddenly. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of events lightheadedness/dizziness and felt a warm flush was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1650562
Sex: F
Age:
State: MS

Vax Date: 03/15/2021
Onset Date: 03/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Excessive ringing in both ears louder each day; increase in migraine headaches; disease recurrence; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the left arm on 15Mar2021 at 09:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. Concomitant medication included propranolol (MANUFACTURER UNKNOWN); taken for unknown indication from an unknown date and unknown if ongoing. The patient previously received codeine (MANUFACTURER UNKNOWN) taken for unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN5318) via an unspecified route of administration in the left arm on 20Feb2021 at 10:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, the patient experienced excessive ringing in both ears - louder each day. It did not go away and the patient wished there was something she could do to stop it. The patient also had an increase in migraine headaches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events excessive ringing in both ears louder each day and increase in migraine headaches were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PROPRANOLOL

Current Illness:

ID: 1650563
Sex: F
Age:
State: VA

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: right arm and hand intermittently tingles; right arm and hand feels very weak; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 05:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, Raynauds syndrome and spondylolisthesis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included lisinopril dihydrate (LISINOPRIL), amlodipine besilate (AMLOR), ascorbic acid, levoglutamide, biotin, folic acid, tyrosine, cyanocobalamin, choline bitartrate, acetylcarnitine, docosahexaenoic acid, panax ginseng root, phosphatidyl choline, phosphatidyl serine, resveratrol, ginkgo biloba leaf, bacopa monnieri herb (PROVASIL), cod-liver oil (FISH OIL) and acetylsalicylic acid (SPRIN); all taken for unknown indication on unknown date, unknown if ongoing. The patient previously took hydrocodone (MANUFACTURER UNKNOWN) and tramadol (MANUFACTURER UNKNOWN) and experienced drug allergy as itch. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 at 05:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 15Apr2021, at 06:00, 1day after receiving the vaccine and subsequent days afterwards, the patient experienced right arm and hand intermittently tingles and right arm and hand feels very weak. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events right arm and hand intermittently tingles and right arm and hand feels very weak. The clinical outcome of the event right arm and hand intermittently tingles were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL; AMLOR; PROVASIL; FISH OIL; SPRIN

Current Illness:

ID: 1650564
Sex: F
Age:
State: GA

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: I have had blurred vision since I got home from getting my first shot; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 07Apr2021 at 09:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as patient was diabetic and had asthma. The patient had previously taken Barbiturates and experienced drug allergy. The patient previously took ciprofloxacin (MANUFACTURER UNKNOWN), chlorhexidine (MANUFACTURER UNKNOWN), styrax benzoin tincture (BENZOIN TINCTURE), theophylline(MANUFACTURER UNKNOWN), montelukast (MANUFACTURER UNKNOWN); all on unknown date for unknown indication and experienced drug allergy. The patient had received other prescribed medications (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient has had blurred vision from 07Apr2021 at 10:30, since she got home from getting her first shot on 07Apr2021 at 09:45. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event had blurred vision since she got home from getting her first shot was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650565
Sex: F
Age:
State: PA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: I noticed the usual symptoms (slight fever, fatigue, headache) but also experienced a strange warming sensation that would come and go in my chest and up into my throat. It feels like I have something; I noticed the usual symptoms (slight fever, fatigue, headache) but also experienced a strange warming sensation that would come and go in my chest and up into my throat. It feels like I have something; I noticed the usual symptoms (slight fever, fatigue, headache) but also experienced a strange warming sensation that would come and go in my chest and up into my throat. It feels like I have something; I have something stuck in my throat; itching; difficulty breathing; cough; This is a spontaneous report from a contactable consumer or other non hcp. This consumer or other non hcp reported information for both mother and fetus/baby. A 32-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19-19 mRNA VACCINE, Formulation: Solution for injection, (Batch/Lot number was not reported)), dose 2 via an unspecified route of administration, administered in the left arm on 15Apr2021 09:45 as dose 2, single for COVID-19 immunization. The patient's medical history included sjogren's syndrome from an unknown date and unknown if ongoing, dysautonomia and functional movement disorder, autonomic nervous system imbalance from an unknown date and unknown if ongoing, migraine from an unknown date and unknown if ongoing, psychogenic movement disorder from an unknown date and unknown if ongoing, connective tissue disorder from an unknown date and unknown if ongoing, narcolepsy from an unknown date and unknown if ongoing, cataplexy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took lactose for drug hypersensitivity, bnt162b2 for COVID-19 immunisation. On 16Apr2021 23:00, the patient experienced that the patient noticed the usual symptoms (slight fever, fatigue, headache) but also experienced a strange warming sensation that would come and go in my chest and up into my throat. It feels like to have something, i have something stuck in my throat, itching, difficulty breathing, cough. The mother reported she became pregnant while taking bnt162b2. The mother was 20 Weeks pregnant at the onset of the event. The mother was due to deliver on 26Aug2021. The mother delivered the pregnancy. I immediately took benadryl to try to stop the itching and it did seem to reduce it enough to a bearable level. This morning, I am still very itchy and have the cough, slight fever. It's more irritating than concerning at this time but was distracting enough I thought I would put in a report. I considered going to the hospital last night, but I have not gotten worse. I do plan to consult my primary care doctor to rule out other possible allergies as well. Therapeutic measures were taken as a result of i noticed the usual symptoms (slight fever, fatigue, headache) but also experienced a strange warming sensation that would come and go in my chest and up into my throat it feels like i have something (headache), i have something stuck in my throat (oropharyngeal discomfort), itching (pruritus), difficulty breathing (dyspnoea), cough (cough). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not tested for COVID-19-19 since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The outcome of the events was not recovered. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1650566
Sex: F
Age:
State: CT

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Nosebleeds; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer and thyroidectomy. The patient had no known allergies to medications, food, or other products. Concomitant medications included thyroid (ARMOUR THYROID), ethinylestradiol, etonogestrel (NUVARING) and unspecified vitamins; all taken for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 16Apr2021 at 18:00, the patient had nosebleeds. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event nosebleeds was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ARMOUR THYROID; NUVARING

Current Illness:

ID: 1650567
Sex: M
Age:
State: MS

Vax Date: 03/29/2021
Onset Date: 03/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8732), at the age of 67, via an unspecified route of administration, left arm, on Mar 29, 2021, single dose, for COVID-19 immunisation. Medical history not available. The patient has no allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 29, 2021, patient experienced pain in upper left arm for three weeks. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of pain in upper left arm: not resolved. No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1650568
Sex: M
Age:
State: NC

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Random sharp heart pain and heart discomfort since getting the vaccine; This is a spontaneous report from a contactable consumer (patient). A 26-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot Number: ER8731) via an unspecified route of administration on 14Apr2021 at 11:00 (at the age of 26-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was reported as none. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had no known allergies. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks of the COVID-19 vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot Number: ER8733) via an unspecified route of administration on 24Mar2021 at 11:00 (at the age of 26-years-old) as a single dose in the left arm for COVID-19 immunization. On 14Apr2021 at 17:00, the patient experienced random sharp heart pain and heart discomfort since getting the vaccine. Treatment was not received for the event. The clinical outcome of the event random sharp heart pain and heart discomfort since getting the vaccine was not recovered/not resolved. Since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1650569
Sex: F
Age:
State: IN

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: started having pain on left lower side/ Kidney causing pain; Urine was very dark Orange; Urine with a horrible odor; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 25Mar2021 at 17:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, high blood pressure and allergy to penicillin. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medications included insulin human (NOVOLIN R), liraglutide (VICTOZA), metformin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and aluminium hydroxide, magnesium hydroxide (MAGNESIUM); all were taken for an unknown indication and from unknown start date. On 25Mar2021 at 19:30, in the evening, the patient started having pain on left lower side, then noticed that the urine was very dark orange with a horrible odor, the patient realized that it was kidney causing pain. Still at the time of this report, the patient had off and on pain in kidney and urine had odor off and on and at times the color was darker. The patient had been terrified to report and also afraid to get the second dose as she did not want to hurt the kidney. The patient almost went to urgent care but did not because she was afraid that it was something serious. The patient was in planning to call the doctor to find out whats going on. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain on left lower side, urine was very dark orange and with a horrible odor was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NOVOLIN R; VICTOZA; METFORMIN; LISINOPRIL; MAGNESIUM

Current Illness:

ID: 1650570
Sex: F
Age:
State: CO

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Could not see; Blurred vision in the left eye; This is a spontaneous report from a contactable consumer (patient). A 53-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 15Apr2021 at 16:15 (Batch/Lot Number: EWU161) as DOSE 2, SINGLE for COVID-19 immunization. Medical history was reported as none. The patient did not have any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ibuprofen (ADVIL) taken for an unspecified indication, start and stop date were not reported. The patient did not receive other vaccinations within four weeks prior to COVID vaccine. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 in the left arm on 25Mar2021 at 16:00 (Batch/Lot Number: ER8727) as DOSE 1, SINGLE for COVID-19 immunization. On 16Apr2021 at 04:30, the patient experienced blurred vision in the left eye; woke up 13 hours after the shot and had foggy vision but not bad; got worse throughout the day; by 24 hours after the shot, complete white out in left eye; could not see. The patient did not receive any treatment for the events. The clinical outcome of the blindness and vision blurred was recovered on 17Apr2021 (by 27 hours started to see improvement; woke up 37 hours after shot with vision back). It was reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: ADVIL [IBUPROFEN]

Current Illness:

ID: 1650571
Sex: M
Age:
State: RI

Vax Date: 04/14/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8735), at the age of 46, via an unspecified route of administration, right arm, on Apr 14, 2021, at 10:30, single dose, for COVID-19 immunisation. Medical history included COVID-19. Patient has no known allergies. Prior to the vaccination, patient diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Patient did not receive any other medications within two weeks of vaccination. On Apr 16, 2021, at 06:00, patient experienced vertigo (dizziness). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of vertigo (dizziness): not recovered (at the time of this report). No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1650572
Sex: F
Age:
State: VA

Vax Date: 04/14/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Chills; fever; underneath arm swollen; underneath my arm is swollen going into the third day after my shot which is painful; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 14Apr2021 at 15:00 (at the age of 50-year-old) as 0.3ml single dose for COVID-19 immunisation. Medical history was reported as no. The patient had no known allergies to food, medications or other products. The patient received medications (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 15:30 the patient experienced chills, fever for two days, underneath arm swollen which was going into the third day after shot and was painful. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of fever was recovered on 17Apr2021 after a duration of 2 days; while that of chills, underneath arm swollen which was going into the third day after shot and was painful was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am